Cargando…
Beneficial Effect of Fenofibrate and Silymarin on Hepatic Steatosis and Gene Expression of Lipogenic and Cytochrome P450 Enzymes in Non-Obese Hereditary Hypertriglyceridemic Rats
The efficacy of fenofibrate in the treatment of hepatic steatosis has not been clearly demonstrated. In this study, we investigated the effects of fenofibrate and silymarin, administered as monotherapy and in combination to existing hepatic steatosis in a unique strain of hereditary hypertriglycerid...
Autores principales: | Vecera, Rostislav, Poruba, Martin, Hüttl, Martina, Malinska, Hana, Oliyarnyk, Olena, Markova, Irena, Racova, Zuzana, Soukop, Jan, Kazdova, Ludmila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164080/ https://www.ncbi.nlm.nih.gov/pubmed/35678658 http://dx.doi.org/10.3390/cimb44050129 |
Ejemplares similares
-
Beneficial effects of troxerutin on metabolic disorders in non-obese model of metabolic syndrome
por: Malinska, Hana, et al.
Publicado: (2019) -
Fenofibrate Decreases Hepatic P-Glycoprotein in a Rat Model of Hereditary Hypertriglyceridemia
por: Poruba, Martin, et al.
Publicado: (2019) -
The Beneficial Additive Effect of Silymarin in Metformin Therapy of Liver Steatosis in a Pre-Diabetic Model
por: Hüttl, Martina, et al.
Publicado: (2021) -
Ovariectomy-Induced Hepatic Lipid and Cytochrome P450 Dysmetabolism Precedes Serum Dyslipidemia
por: Malinská, Hana, et al.
Publicado: (2021) -
Downregulation of the Glo1 Gene Is Associated with Reduced Adiposity and Ectopic Fat Accumulation in Spontaneously Hypertensive Rats
por: Šilhavý, Jan, et al.
Publicado: (2020)